ITEMS IN AFP WITH KEYWORD:
Erenumab is a safe option for migraine prophylaxis in adults. However, it is expensive and should be reserved for patients who have experienced intolerable adverse effects while taking oral migraine prophylaxis medication or who have poor adherence to daily preventive treatment.
Mar 1, 2019 Issue
Hemorrhoids, Tremor, C. difficile Infection, Migraine, Vitamin D Screening [AFP Clinical Answers]
Key clinical questions and their evidence-based answers directly from the journal’s content, written by and for family physicians.
Preventive therapy has been shown to be beneficial to many patients with episodic migraines. Indications for therapy include four or more headaches or eight or more headache days a month, debilitating headaches, and medication-overuse headaches. First- and second-line medications are available for treatment; managing environmental, dietary, and behaviorial triggers is useful in preventive therapy. Nonpharmacologic prevention options are also discussed.
Aug 15, 2018 Issue
Identifying Patients with Headache Who Are at Risk of Subarachnoid Hemorrhage [Point-of-Care Guides]
When is urgent imaging warranted in patients presenting with sudden, severe, nontraumatic headache and normal findings on a neurologic examination?
Migraine is a chronic condition characterized by recurrent attacks. Acetaminophen, nonsteroidal anti-inflammatory drugs, triptans, antiemetics, ergot alkaloids, and combination analgesics have evidence supporting their effectiveness. Learn about the three treatment strategies recommended for migraine and when to consider prophylactic therapy.
There is moderate-quality evidence that whole-body acupuncture is effective for migraine prevention. Compared with usual care, acupuncture is more effective at reducing headache frequency by at least 50% (number needed to treat [NNT] = 4).
Topiramate, amitriptyline, and placebo all led to a similar, substantial improvement in migraine frequency and disability. How to harness this strong placebo effect for our patients is an important, but unanswered, question.
Feb 1, 2017 Issue
AAN Updates Guidelines on the Uses of Botulinum Neurotoxin [Practice Guidelines]
In 2008, the American Academy of Neurology (AAN) published guidelines on the use of botulinum neurotoxin. This summary highlights updates on four indications: blepharospasm, cervical dystonia, spasticity in adults, and headache.
Evidence supports current guideline recommendations on the use of valproate medications to prevent migraine.
Studies show an NNT of 3 to have at least a 50% reduction of headache frequency compared with routine care. Want to know more?